{"address1": "333 Lakeside Drive", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 574 3000", "fax": "650 578 9264", "website": "https://www.gilead.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.", "fullTimeEmployees": 17600, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel P.  O'Day", "age": 59, "title": "Chairman & CEO", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 7137565, "exercisedValue": 0, "unexercisedValue": 30103994}, {"maxAge": 1, "name": "Mr. Andrew D. Dickinson", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 2729705, "exercisedValue": 5536695, "unexercisedValue": 8763160}, {"maxAge": 1, "name": "Ms. Deborah H. Telman J.D.", "age": 59, "title": "Executive VP of Corporate Affairs, General Counsel & Corporate Secretary", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 3107954, "exercisedValue": 0, "unexercisedValue": 1127163}, {"maxAge": 1, "name": "Ms. Johanna  Mercier", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 3169442, "exercisedValue": 0, "unexercisedValue": 12195903}, {"maxAge": 1, "name": "Ms. Diane E. Wilfong", "age": 62, "title": "Interim Corporate Controller, Chief Accounting Officer & Principal Accounting Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jacquie  Ross C.F.A.", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jyoti K. Mehra", "age": 47, "title": "Executive Vice President of Human Resources", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Linda Slanec Higgins Ph.D.", "age": 62, "title": "Senior Vice President of Research, Innovation & Portfolio", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rudolf  Ertl", "age": 78, "title": "Senior Vice President of Commercial Operations of Australia, Canada, Europe", "yearBorn": 1946, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Flavius  Martin M.D.", "title": "Executive Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 5, "compensationRisk": 5, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 109.11, "open": 108.11, "dayLow": 107.39, "dayHigh": 108.77, "regularMarketPreviousClose": 109.11, "regularMarketOpen": 108.11, "regularMarketDayLow": 107.39, "regularMarketDayHigh": 108.77, "dividendRate": 3.16, "dividendYield": 2.9, "exDividendDate": 1749772800, "payoutRatio": 0.65129995, "fiveYearAvgDividendYield": 3.97, "beta": 0.282, "trailingPE": 22.689075, "forwardPE": 14.535666, "volume": 4871487, "regularMarketVolume": 4871487, "averageVolume": 9930529, "averageVolume10days": 10103060, "averageDailyVolume10Day": 10103060, "bid": 102.15, "ask": 114.12, "bidSize": 1, "askSize": 1, "marketCap": 134344441856, "fiftyTwoWeekLow": 62.07, "fiftyTwoWeekHigh": 119.96, "priceToSalesTrailing12Months": 4.675289, "fiftyDayAverage": 106.0884, "twoHundredDayAverage": 94.1566, "trailingAnnualDividendRate": 3.1, "trailingAnnualDividendYield": 0.028411694, "currency": "USD", "tradeable": false, "enterpriseValue": 151882104832, "profitMargins": 0.20759001, "floatShares": 1241341748, "sharesOutstanding": 1243929984, "sharesShort": 23574395, "sharesShortPriorMonth": 21390611, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0189, "heldPercentInsiders": 0.00124, "heldPercentInstitutions": 0.89732003, "shortRatio": 2.4, "shortPercentOfFloat": 0.0189, "impliedSharesOutstanding": 1243929984, "bookValue": 15.391, "priceToBook": 7.017088, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 5965000192, "trailingEps": 4.76, "forwardEps": 7.43, "lastSplitFactor": "2:1", "lastSplitDate": 1359331200, "enterpriseToRevenue": 5.286, "enterpriseToEbitda": 11.067, "52WeekChange": 0.60929203, "SandP52WeekChange": 0.11936104, "lastDividendValue": 0.79, "lastDividendDate": 1741910400, "quoteType": "EQUITY", "currentPrice": 108.0, "targetHighPrice": 140.0, "targetLowPrice": 92.0, "targetMeanPrice": 115.03769, "targetMedianPrice": 116.0, "recommendationMean": 1.86667, "recommendationKey": "buy", "numberOfAnalystOpinions": 26, "totalCash": 8711000064, "totalCashPerShare": 7.003, "ebitda": 13724000256, "totalDebt": 24952000512, "quickRatio": 1.061, "currentRatio": 1.369, "totalRevenue": 28735000576, "debtToEquity": 130.789, "revenuePerShare": 23.048, "returnOnAssets": 0.121429995, "returnOnEquity": 0.32654998, "grossProfits": 22496000000, "freeCashflow": 9989000192, "operatingCashflow": 10366000128, "revenueGrowth": -0.003, "grossMargins": 0.78288, "ebitdaMargins": 0.47761002, "operatingMargins": 0.38487998, "financialCurrency": "USD", "symbol": "GILD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [{"header": "Dividend", "message": "GILD announced a cash dividend of 0.79 with an ex-date of Jun. 13, 2025", "meta": {"eventType": "DIVIDEND", "dateEpochMs": 1749787200000, "amount": "0.79"}}], "regularMarketTime": 1747856181, "exchange": "NMS", "messageBoardId": "finmb_29002", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": -1.1100006, "regularMarketDayRange": "107.39 - 108.77", "fullExchangeName": "NasdaqGS", "hasPrePostMarketData": true, "shortName": "Gilead Sciences, Inc.", "marketState": "REGULAR", "regularMarketChangePercent": -1.0173225, "regularMarketPrice": 108.0, "firstTradeDateMilliseconds": 696090600000, "averageDailyVolume3Month": 9930529, "fiftyTwoWeekLowChange": 45.93, "fiftyTwoWeekLowChangePercent": 0.739971, "fiftyTwoWeekRange": "62.07 - 119.96", "fiftyTwoWeekHighChange": -11.959999, "fiftyTwoWeekHighChangePercent": -0.09969989, "fiftyTwoWeekChangePercent": 60.929203, "dividendDate": 1750982400, "earningsTimestamp": 1745524920, "earningsTimestampStart": 1754477940, "earningsTimestampEnd": 1754913600, "earningsCallTimestampStart": 1745526600, "earningsCallTimestampEnd": 1745526600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 4.76, "epsForward": 7.43, "epsCurrentYear": 7.98043, "priceEpsCurrentYear": 13.533105, "fiftyDayAverageChange": 1.9115982, "fiftyDayAverageChangePercent": 0.018018918, "twoHundredDayAverageChange": 13.843399, "twoHundredDayAverageChangePercent": 0.14702526, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "longName": "Gilead Sciences, Inc.", "displayName": "Gilead Sciences", "trailingPegRatio": 0.2279}